Delivery Order SPE2DB22D3016-SPE2DB24FAHX1
Award Date 1/9/24
Potential Completion Date 1/31/24
Potential Value $111K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical OCREVUS. The $131,171.40 award has an August 24, 2022 completion date and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a prime contractor that has received numerous prior DLA contract awards to provide pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The $163,964.25 award has a completion date of March 10, 2022 and was made on February 16, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received multiple DLA awards to provide pharmaceuticals, medical supplies, and related distribution services in...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide OCREVUS 300 MG/10 ML VIAL 10ML. The contract has a potential value of $92,472.32 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The order has a potential value of $23,118.08 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OCREVUS 300 MG/10 ML VIAL 10ML. The $23,118.08 contract has a June 3, 2024 ultimate completion date. This award is made under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) awarded a $92,472.32 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ocrevus 300 mg/10 ml vials in support of DLA Troop Support Medical. This delivery order contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous awards from DLA to supply pharmaceuticals, medical supplies, and distribution...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $46,236.16. The order is for the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML and has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $109,309.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order was placed under a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical. The contract has a performance location of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The contract has a potential value of $34,677.12 and a completion date of March 7, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML vials. The $109,309.50 award has an April 7, 2022 completion date and was issued on March 17, 2022. AmerisourceBergen, a large pharmaceutical distributor, has previously received numerous DLA delivery orders to supply pharmaceuticals, medical supplies, and distribution services in...